rs116156469
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_138694.4(PKHD1):c.6184C>T(p.Leu2062=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000697 in 1,613,288 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L2062L) has been classified as Likely benign.
Frequency
Consequence
NM_138694.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PKHD1 | NM_138694.4 | c.6184C>T | p.Leu2062= | synonymous_variant | 38/67 | ENST00000371117.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PKHD1 | ENST00000371117.8 | c.6184C>T | p.Leu2062= | synonymous_variant | 38/67 | 1 | NM_138694.4 | P2 | |
PKHD1 | ENST00000340994.4 | c.6184C>T | p.Leu2062= | synonymous_variant | 38/61 | 5 | A2 |
Frequencies
GnomAD3 genomes ? AF: 0.00256 AC: 390AN: 152082Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.00129 AC: 324AN: 251120Hom.: 2 AF XY: 0.00119 AC XY: 162AN XY: 135700
GnomAD4 exome AF: 0.000498 AC: 727AN: 1461088Hom.: 7 Cov.: 31 AF XY: 0.000510 AC XY: 371AN XY: 726902
GnomAD4 genome ? AF: 0.00261 AC: 397AN: 152200Hom.: 4 Cov.: 32 AF XY: 0.00227 AC XY: 169AN XY: 74420
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 26, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 01, 2020 | - - |
Autosomal recessive polycystic kidney disease Benign:2
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | May 11, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Polycystic kidney disease Benign:1
Likely benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The PKHD1 p.Leu2062= variant was not identified in the literature nor was it identified in the LOVD 3.0, RWTH AAachen University ARPKD databases. The variant was identified in dbSNP (ID: rs116156469) as “With Likely benign allele”, ClinVar (as likely benign by Prevention Genetics), and Clinvitae (1x as “likely benign”). The variant was identified in control databases in 381 of 276812 chromosomes at a frequency of 0.001376 in the following populations: African in 212 (2 homozygous) of 24028 chromosomes (freq. 0.0088), Ashkenazi Jewish in 46 of 10140 chromosomes (freq. 0.0045), South Asian in 78 (2 homozygous) of 30782 chromosomes (freq. 0.0025), Other in 9 of 6456 chromosomes (freq. 0.001), Latino in 21 of 34338 chromosomes (freq. 0.0006), and European (Non-Finnish) in 15 of 126444 chromosomes (freq. 0.0001) increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Consortium Feb 27, 2017). The p.Leu2062= variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 18, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at